CHMP5 and COVID-19: The trend observed for neutralizing antibody titers among both the COVID-19 and MIS-C cohorts was confirmed by the antibody binding against the RBD of WA1, BA.1, BA.2.75, and BA.4/BA.5 spike proteins using SPR (Figure 4).